Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,165.08
(
0.80%
)
US TECH 100
26,598.80
(
0.16%
)
Dow Jones
49,230.71
(
-0.16%
)
Brent Oil
100.83
(
-0.69%
)
Bitcoin
77,820.24
(
-1.06%
)
News Focus
News Focus
Post# of 257443
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122886
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 208697

Friday, 02/03/2017 10:42:37 AM

Friday, February 03, 2017 10:42:37 AM

Post# of 257443

Do you view [Repatha CVOT] news as positive for ESPR?

Yes, to a degree; however, until we know the HR achieved on the primary MACE endpoint in the Repatha CVOT, I would remain cautious. The 20% pop for ESPR may be an overreaction.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today